Skip to main content

Aethlon Medical Inc 10-Q for FY2027 Q2

Aethlon Medical Inc (AEMD)

10-Q 2026-11-12 For: 2026-09-30
View Original
Added on November 12, 2026

About this 10-Q

Aethlon Medical Inc filed this 10-Q on November 12, 2026, covering the quarter ended September 30, 2026 (FY2027 Q2).

Aethlon Medical agreed to merge with North Immunology, a two-step transaction expected to close in first calendar quarter 2027. The six-month net loss rose to $4,165,000, while cash was $6,486,639 as of September 30, 2026. AI summary

Headline figures

Quarter ended September 30, 2026, as reported in this filing, compared with the same period a year earlier where the filing states it.

Net loss
$2.62M
compared with a net loss of $1.49M a year earlier
Diluted EPS
-$2.60
compared with -$18.70 a year earlier